Dallas-based biotechnology company OncoNano Medicine has secured $15 million in grant funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced Aug. 27 and financed by Cancer Prevention and Research Institute of Texas.
According to its Crunchbase profile, "OncoNano Medicine is a biotech company that develops nanotechnology-enabled fluorescent probes to help cancer surgeons visualize tumors during surgery, allowing them to excise tumors more precisely. The fluorescent sensor targets the different pH signals, thus making them glow so they are easier to distinguish from normal tissue. OncoNano Medicine is a UTSW spinoff company based in Dallas, Texas."
The has raised three previous funding rounds, including a $23 million Series A round earlier this year.
The round brings total funding raised by Dallas companies in biotechnology over the past 90 days to $39 million, an increase of $17 million from the previous three-month period. The local biotechnology industry has seen six funding rounds over the past year, capturing a total of $199 million in venture funding.
In other local funding news, e-commerce company Neighborhood Goods announced a $11 million Series A funding round on Sept. 11, led by Global Founders Capital.
According to Crunchbase, "Neighborhood Goods is a department store that features the landscape of the world’s brands, products and concepts. More than that, Neighborhood Goods is a community, bringing thoughtful people together to shop, eat and learn in our vibrant physical spaces, through their immersive editorial content and more. Founded in 2017, Neighborhood Goods is headquartered in Dallas, Texas."
Founded in 2017, the company has raised two previous rounds, including a $8.8 million seed round earlier this year.
This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.
